AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Scinai Immunotherapeutics Ltd. American Depositary Shares
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG007TGL3Q9
0.56▼ 0.05 (-7.60%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
0.61
Day's Range
0.55 – 0.59
52-Week Range
0.21 – 3.58
Volume
36.8K
Avg Volume
4.2M
Share Statistics
Shares Outstanding
Employees
45
Exchange
XNAS
Listed
2015-05-12
Share count as of August 20, 2026

Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI)
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Market Cap?
Scinai Immunotherapeutics Ltd. American Depositary Shares's Market Cap is $15.3B, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Price / Sales?
Scinai Immunotherapeutics Ltd. American Depositary Shares's Price / Sales is 11670.3×, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Revenue (TTM)?
Scinai Immunotherapeutics Ltd. American Depositary Shares's Revenue (TTM) is $1.3M, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Net Income (TTM)?
Scinai Immunotherapeutics Ltd. American Depositary Shares's Net Income (TTM) is -$8.3M, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's EBITDA?
Scinai Immunotherapeutics Ltd. American Depositary Shares's EBITDA is -$6.1M, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Diluted EPS (TTM)?
Scinai Immunotherapeutics Ltd. American Depositary Shares's Diluted EPS (TTM) is -0.00, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's EBITDA Margin?
Scinai Immunotherapeutics Ltd. American Depositary Shares's EBITDA Margin is -466.9%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SCNIAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(as filed, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2023Mar 31, 2022
Research and development expenses, net
Total operating profit (loss)
Total Financial Income (Expenses) net,
Net profit (loss)
Net loss per share attributable to ordinary shareholders, basic (in Dollars per share)
Net loss per share attributable to ordinary shareholders, diluted (in Dollars per share)—